ArticleFrontiers in immunology2021

Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients.

Joanne E Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.